Eventide Asset Management’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-413,906
| Closed | -$14.1M | – | 168 |
|
|
2023
Q3 | $14.1M | Hold |
413,906
| – | – | 0.25% | 104 |
|
|
2023
Q2 | $15.9M | Sell |
413,906
-227,294
| -35% | -$8.75M | 0.27% | 99 |
|
|
2023
Q1 | $22.9M | Hold |
641,200
| – | – | 0.42% | 73 |
|
|
2022
Q4 | $25.3M | Hold |
641,200
| – | – | 0.5% | 65 |
|
|
2022
Q3 | $23.1M | Buy |
641,200
+171,500
| +37% | +$6.19M | 0.46% | 70 |
|
|
2022
Q2 | $14.3M | Buy |
+469,700
| New | +$14.3M | 0.31% | 84 |
|
|
2021
Q3 | – | Sell |
-1,490,000
| Closed | -$27.7M | – | 161 |
|
|
2021
Q2 | $27.7M | Hold |
1,490,000
| – | – | 0.37% | 76 |
|
|
2021
Q1 | $26.7M | Buy |
1,490,000
+459,860
| +45% | +$8.23M | 0.4% | 80 |
|
|
2020
Q4 | $15.8M | Sell |
1,030,140
-243,960
| -19% | -$3.75M | 0.24% | 95 |
|
|
2020
Q3 | $14.1M | Hold |
1,274,100
| – | – | 0.28% | 91 |
|
|
2020
Q2 | $16M | Hold |
1,274,100
| – | – | 0.35% | 75 |
|
|
2020
Q1 | $14.4M | Hold |
1,274,100
| – | – | 0.47% | 64 |
|
|
2019
Q4 | $16.7M | Hold |
1,274,100
| – | – | 0.47% | 66 |
|
|
2019
Q3 | $11.5M | Hold |
1,274,100
| – | – | 0.38% | 73 |
|
|
2019
Q2 | $12.6M | Buy |
1,274,100
+653,409
| +105% | +$6.44M | 0.38% | 76 |
|
|
2019
Q1 | $6.31M | Buy |
620,691
+196,258
| +46% | +$1.99M | 0.22% | 85 |
|
|
2018
Q4 | $2.68M | Buy |
424,433
+109,433
| +35% | +$690K | 0.12% | 98 |
|
|
2018
Q3 | $4.16M | Buy |
+315,000
| New | +$4.16M | 0.15% | 103 |
|